National Institute for Health and Clinical Excellence (NICE)
Helping people avoid early death – NICE publishes new support for local government on tackling the causes of poor health
Helping local authorities to tackle the direct causes of early death is the focus of a new briefing from NICE.
Early death means dying before the age of 75. One in every three people who dies in England is aged under 75 – two-thirds of these deaths are avoidable. Many of the direct causes of death, such as heart disease and cancer, follow long periods of bad health which is often caused by lifestyle factors.
NICE’s briefing focuses on the actions that local authorities can take to reduce early death; to address lifestyle issues that lead to poor health; to improve access to services; and to prevent unintentional injuries.
Underlying factors, such as bad housing and poor working conditions, can lead to illness and early death. For example, children who live in a deprived area are at greater risk of being injured in an accident - a leading cause of death in children and young people. As well as affecting a person’s physical and mental wellbeing, these wider social factors can influence their lifestyle choices – such as smoking or drinking alcohol – which cause early death. People on low incomes are twice as likely to smoke and 3–5 times more likely to die from conditions caused by alcohol misuse such as chronic liver disease and cirrhosis.
This briefing highlights the opportunity for local authorities to connect the work they have been doing for years on the wider factors behind poor health, to their more recent remit for supporting healthier lifestyles for individuals and communities.
Drawing on a wealth of NICE public health guidance recommendations, from smoking cessation, to physical activity, to detecting chronic conditions like type 2 diabetes, the briefing supports local government in making changes needed to improve the health of local people, and saving lives.
Professor Gillian Leng, Deputy Chief Executive at NICE said: “Taking early action to tackle issues such as smoking, excessive alcohol consumption and obesity could save about 103,000 people from dying early each year in England. This new briefing pulls together recommendations from a wide range of NICE guidance to help local government use effective practical ways to address the direct causes of illness and early death.
“For example advice on health eating highlights using supplier opportunities to influence healthy lifestyle choices, such as ensuring that catering contracts encourage a healthy balanced diet. Local government can also use existing powers to control the number of take-away and other food outlets in a given area. On smoking, there’s advice on encouraging employers to publicise stop-smoking services and think about commissioning them for their workplace. Running health promotion campaigns on infectious diseases and vaccinations is another way to raise awareness in local populations on protecting health.”
Examples of effective actions highlighted in the new briefing include:
- Help prevent, detect and manage infectious and chronic clinical conditions that can lead to premature mortality, using, for example, NHS Health Check and routine and opportunistic screening
- Ensure leisure and other services are affordable, culturally acceptable and accessible to all, including women who wish to breastfeed
- Introduce integrated population-wide programmes that address local health inequalities and improve access for those who do not routinely use services
- Create, protect and manage safe spaces for physical activity and plan local facilities and services to ensure they are accessible on foot or by bicycle. This includes reviewing local bye laws that may discourage physical activity and using pricing and educational initiatives.
For more information call Dr Tonya Gillis at the NICE press office on 0300 323 0142 or out of hours on 07775 583 813.
Notes to Editors
About the new Local Government Briefing
1. The new briefing, ‘Tackling the causes of premature mortality (early death)’, is published on 20 February 2015, and is available at:http://www.nice.org.uk/advice/LGB26
2. This new publication is part of a suite of briefing documents which NICE is producing to provide support to local government. This new area of work aims to help councillors and local authority staff find out which public health actions are most effective in improving the health of people in their area, while also providing the best value for money. Based on recommendations from existing NICE public health and clinical guidance, the briefings have been developed with input from the independent Local Government Reference Group. The group comprises councillors, local government officers, and others with an interest in community health and wellbeing. The new briefings are in addition to NICE’s ongoing programme producing public health guidance. Topics covered include tobacco, physical activity and workplace health, alcohol, health inequalities and behaviour change.
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for driving improvement and excellence in the health and social care system. We develop guidance, standards and information on high-quality health and social care. We also advise on ways to promote healthy living and prevent ill health.
Our aim is to help practitioners deliver the best possible care and give people the most effective treatments, which are based on the most up-to-date evidence and provide value for money, in order to reduce inequalities and variation.
Our products and resources are produced for the NHS, local authorities, care providers, charities, and anyone who has a responsibility for commissioning or providing healthcare, public health or social care services.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
Wireless device recommended for treating people with overactive bladder14/02/2020 12:15:00
Axonics SNS has potential to save the NHS around £6,200 per patient if the device lasts more than six years
Researchers wanted to study the public’s views of health-related quality of life13/02/2020 11:15:00
Researchers have been asked to express their interest in running a study of the UK public’s valuation of health-related quality of life.
Appeal panel rules that NICE needs to request evidence for erenumab effectiveness in subgroup of people with chronic migraine05/02/2020 14:15:00
NICE yesterday (4 February 2020) published the outcome of the appeal against its final draft guidance (FAD) on erenumab (also called Aimovig and made by Novartis) for preventing chronic migraine.
Broader types of data to be used in development of NICE guidance04/02/2020 16:15:00
An expanded evidence base could allow NICE to address evidence gaps and enhance reviews of the impact of our guidance.
NICE publishes updated principles31/01/2020 15:25:00
NICE has published a simple guide to the way we develop our guidance and standards.
Nasal spray medicine for treatment-resistant depression not recommended by NICE29/01/2020 11:15:00
More evidence on the clinical and cost effectiveness of esketamine needed.
Digital and mobile interventions could support regular health services in helping people stop smoking and reduce their risk of obesity, says NICE24/01/2020 11:15:00
Health professionals can consider digital and mobile interventions as a supplement to regular services to support behaviour change in people at risk of developing chronic conditions.
Care matters – Working together to get support right for adult carers23/01/2020 11:15:00
Dame Philippa Russell, Vice-President of Carers UK and Topic Adviser for the NICE guideline on Supporting Adult Carers.
NICE encourages further data collection on ‘game changing’ histology independent cancer drugs17/01/2020 14:10:00
Larotrectinib (also called Vitrakvi and made by Bayer), a new treatment for a range of cancers, can’t be recommended for use in the NHS because at its current price, it doesn’t have the potential to be cost-effective.